About the Szent-Györgyi Prize
The Szent-Györgyi Prize for Progress in Cancer Research is named in memory of Dr. Albert Szent-Györgyi, NFCR’s co-founder and 1937 Nobel Laureate for his study of vitamin C and cell respiration. The prize is a symbol of NFCR’s enduring commitment to uphold Dr. Szent-Györgyi’s vision of curing cancer through innovation and collaboration.
The annual Prize honors scientists whose seminal discovery or pioneering body of work has contributed to cancer prevention, diagnosis, or treatment and has had a lasting impact on understanding cancer, holding the promise of improving or saving lives of cancer patients.
The Szent-Györgyi Prize serves to stimulate continued investment in the pioneering research that will produce scientific breakthroughs and promote public awareness of the importance of basic cancer research and the need to accelerate the translation of these research discoveries into new cancer treatments. In addition to winning the coveted award itself, prize recipients are given a $30,000 honorarium and attend a gala in their honor.
Current Winner
Our 2022 Awardee is being recognized for overcoming barriers in the tumor microenvironment to improve efficacy of anti-cancer medicines
About the Ceremony
Our next ceremony will take place on October 22, 2022 in Washington, DC.
Stay tuned for more details!
Past Winners
View all previous awardees of the Szent-Gyorgyi Prize for Progress in Cancer Research.
